About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
https://www.soho2019.com/
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
G
New Therapeutic Strategies in MDS: Increased Role of Genomic Annotation, Multiple New Targets, New Ongoing Phase III Trials
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Guillermo Garcia-Manero
By
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
FEATURING
Guillermo Garcia-Manero
11 views
November 18, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Myelodysplastic Syndromes
13:27
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
New Therapeutic Strategies in MDS: Increased Role of Genomic Annotat…
Feat.
G. Garcia-Manero
13:28
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Progress in Targeting the TGFb Pathway in MDS: TGF-Beta Inhibitors S…
Feat.
A. Verma
13:12
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Managing TP53-Mutant MDS in 60 y/o Female w/ PMH of Stage 2 Breast A…
Feat.
D. Sallman
15:31
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Is TELESTO Trial the Final Answer to Iron Chelation Therapy in MDS?
Feat.
E. Angelucci
15:54
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
The Role of DNA Methyltransferase Inhibitors in the Modern Therapy o…
Feat.
M. Savona
14:28
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Preventing Relapse in MDS After alloTx: Relapse Remains Major Challe…
Feat.
U. Platzbecker
06:11
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Ring Sideroblast Quantification is Highly Predictive of TP53 Mutatio…
Feat.
D. Swoboda
04:30
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
Demographics and Survival in Atypical Chronic Myeloid Leukemia: SEER…
Feat.
N. Anusim
